New Report Provides an in-Depth Discussion on Recent Developments of Nanoparticle Enabled Drug Delivery Systems (DDS) and Future Opportunities.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c68525) has announced the addition of Nanoparticle Drug Delivery Market Report to their offering. This report will give Pharma investors a comprehensive understanding on the impact of nanotechnologies on the pharmaceutical market and companies, which include companies that are producing nanomaterials/technologies to enable better drug delivery compounds (drug delivery company) and companies that are using nano-enabled formulations to enhance drug delivery (drug formulation company). This report will provide an in-depth discussion on recent developments of nanoparticle enabled drug delivery systems (DDS (1) (Digital Data Storage) See DAT. (2) (Data Dictionary System) See QuickBuild and OpenDDS. (3) (Dataphone Digital S ) and future opportunities. It is tailored for investors who plan to invest in the pharmaceutical industry with an eye towards how nanoparticle drug delivery technology will impact the economics of the pharmaceutical market. The information includes business summaries, technology core competencies, how nanoparticle adds value for investors in drug delivery companies, commercialization strategies, intellectual property and available markets. There are 58 case studies on nanoparticle DDS listed according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. 3 categories: -Delivery Method/Routes of administration Oral administration Transdermal delivery Injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. delivery Topical delivery Inhaled/nasal/pulmonary delivery Implantable delivery -Therapeutics Cancer therapy Vaccines Antibody DNA-based therapy -Technology Nanoparticulate encapsulation (1) In object technology, the creation of self-contained modules that contain both the data and the processing. See object-oriented programming. (2) The transmission of one network protocol within another. Dendrimer-based targeted therapeutics technology Liposomes Liposomes Aqueous compartments enclosed by lipid bilayer membranes; liposomes are also known as lipid vesicles. Phospholipid molecules consist of an elongated nonpolar (hydrophobic) structure with a polar (hydrophilic) structure at one end. nanotechnology Nanotube A carbon molecule that resembles a cylinder made out of chicken wire one to two nanometers in diameter by any number of millimeters in length. Accidentally discovered by a Japanese researcher at NEC in 1990 while making Buckyballs, they have potential use in many applications. technologies Nanoparticles coating technology Silica-chitosan nanocomposite Nanosome technology We provide a nanotechnology model based on primary research quantifying the impact and diffusion of nanotechnologies by industry sector over time. The model takes into account global R&D spending on nanotechnologies and assumes a median seven year time lag between the start of a funding program and a commercially useful output, industry R&D growth rates Growth Rates The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures. Notes: Remember, historically high growth rates don't always mean a high rate of growth looking into the future. , global GDP GDP (guanosine diphosphate): see guanine. growth predictions and the rate of penetration of nanotechnologies based on primary research to develop the rate of diffusion by industry sector. Content Outline: EXECUTIVE SUMMARY AIM, SCOPE AND ORGANIZATION OF REPORT CIENTIFICA NANOTECHNOLOGY MODEL Definitions of Nanotechnologies Major Assumptions BACKGROUND MARKET FORECAST & OVERVIEW INTRODUCTION TO THE MARKETS NANOPHARMACEUTICALS NANOTECHNOLOGY IN DRUG DELIVERY NANOBIOTECHNOLOGY IN DRUG DELIVERY OTHER APPLICATIONS FOR NANOMATERIALS IN THE MEDICAL AND PHARMACEUTICAL SECTOR TRENDS AND NEEDS ROADMAP NANOTECHNOLOGY INFLUENCE IN PHARMACEUTICAL VALUE CHAIN ANALYTICAL TECHNIQUES FOR NANOPARTILE DRUG DELIVERY NANOPARTICLES AS DRUG CARRIERS PROJECTED PRODUCT PIPELINE FOR NANOPARTICLE IN DRUG DELIVERY MARKET DRUG DELIVERY CHALLENGES -- WHY DRUG DELIVERY & WHY NANOPARTICLES THE NEED FOR BETTER DRUG THERAPY THE NEED FOR DRUG SOLUBILITY solubility Degree to which a substance dissolves in a solvent to make a solution (usually expressed as grams of solute per litre of solvent). Solubility of one fluid (liquid or gas) in another may be complete (totally miscible; e.g. THE NEED FOR SITE-SPECIFIC AND ORGAN-SPECIFIC IN FUNCTION DRIVERS AND OPPORTUNITIES FOR NANOPARTICLE DRUG DELIVERY THE AIM OF DRUG TARGETING REASONS WHY THE DRUG DELIVERY MARKET IS RAPIDLY EXPANDING MARKET DRIVERS FOR ENHANCED DRUG DELIVERY THE ADVANTAGES OF USING POLYMERIC NANOPARTICLES (PNPS PNPS Programme National de Physique Stellaire PNPS Pennsylvania Native Plant Society PNPS Plug and Play Specifications PNPS Plug and Play System ) IN DRUG DELIVERY EXPANDING GOVERNMENTAL FUNDING DRIVES THE NANOBIOTECHNOLOGY MARKET HOW DRUG COMPANIES ARE REACTING TO THIS EXPANSION FUTURE BARRIERS AND CHALLENGES BIG PHARMACEUTICAL COMPANIES RELUCTANT TO INVEST IN UNTRIED TECHNOLOGIES LACK OF REGULATORY CASE LAW LONG ADMISSION PROCEDURES INCLUDING FOR EXAMPLE SEVERAL CLINICAL TRIALS A NEED FOR RAPID SCREENING METHODS SCALABILITY OF NANOPARTICLE PRODUCTION AN URGENT NEED FOR ANALYTICAL METHODS A NEED FOR THE INVESTIGATION OF FURTHER NANOPARTICLES THE POTENTIAL TOXICITY OF ENGINEERED NANOPARTICLES IS AN UNSOLVED ISSUE AND STILL NEEDS TO BE DEALT WITH THE FUTURE OF NANO AND BIO COLLABORATIONS IS PROMISING NANOPARTICLE ADDED VALUE Added value in financial analysis of shares is to be distinguished from value added. Used as a measure of shareholder value, calculated using the formula:
CASE STUDY -- UNIVERSITY OF MICHIGAN'S NANOPARTICLE-BASED PAIN RELIEF STUDY FOR MILITARY BATTLEFIELD USE CASE STUDY -- ACUSPHERE'S HYDROPHOBIC hydrophobic /hy·dro·pho·bic/ (-fo´bik) 1. pertaining to hydrophobia (rabies). 2. not readily absorbing water, or being adversely affected by water. 3. DRUG DELIVERY SYSTEM (HDDS HDDS Hazards Data Distribution System HDDS High-Density Data System HDDS Hull Design Database System HDDS Hazardous Device Disposal Squad HDDS Hold Deck Deck Switch HDDS Hydro-Dynamic Device Simulator [TM]) FOR REFORMULATION OF HYDROPHOBIC DRUGS CASE STUDY -- IMARX'S HYDROPLEX[TM] PLATFORM FOR DELIVERING HYDROPHOBIC DRUGS CASE STUDY - ALPHARX'S NANOPARTICLE DRUG DELIVERY PLATFORM FOR ANTIBIOTIC DRUGS CASE STUDY - CYTRX'S RNAI NANOPARTICLE DELIVERY TECHNOLOGY FOR RNAI THERAPEUTICS INVESTING IN NANOPARTCLE-ENABLED DRUG DELIVERY INDUSTRY CASE STUDY - NANOTHERAPEUTICS' COMMERCIALISATION STRATEGY CASE STUDY - HOW CAN NANOVINDEX'S NANOPARTICLE HYDROGEL hy·dro·gel n. A colloidal gel in which the particles are dispersed in water. hydrogel a gel that contains water. hydrogel Wound care A polymer absorptive wound dressing. See Dressing. COMPOSITES ADD VALUE FOR DRUG DELIVERY INVESTORS CASE STUDY -- KEYSTONE NANO'S MOLECULAR DOTS (MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there ) COMMERCIALISATION STRATEGY CASE STUDY - NANOCARRIER'S PROTEINS NANOENCAPSULATION SEEKING OUT BIG BIOTECH BUSINESS CASE STUDY -- NANOBIOMAGNETICS' BUSINESS MODEL FOR ORGAN-ASSISTING-DEVICE (OAD) TECHNOLOGIES CASE STUDY - HOW CAN AVIDIMER THERAPEUTICS' AVIDIMERS PLATFORM TECHNOLOGY ADD VALUE FOR DRUG DELIVERY INVESTORS CASE STUDY -- CAPSULUTION'S COMMERCIALISATION STRATEGY FOR LBL-TECHNOLOGY[R]-BASED DRUG DELIVERY SYSTEMS CASE STUDY -- ACCESS PHARMACEUTICALS' PRODUCT PIPELINE FOR COBALAMIN cobalamin: see coenzyme; vitamin. [TM]- MEDIATED DISEASE TARGETING CASE STUDY - AZAYA THERAPEUTICS' PRODUCT PIPELINE FOR PROTEIN STABILIZED LIPOSOME liposome (lī`pəsōm', lĭp`ə–), microscopic, fluid-filled pouch whose walls are made of layers of phospholipids identical to the phospholipids that make up cell membranes. (PSL 1. PSL - Portable Standard Lisp. 2. PSL - Problem Statement Language. See PSL/PSA. [TM]) NANOTECHNOLOGY NANOPARTICLE DRUG DELIVERY SYSTEM BY DELIVERY METHOD/ROUTES OF ADMINISTRATION DELIVERY METHOD ORAL ADMINISTRATION TRANSDERMAL DELIVERY INJECTABLE DELIVERY TOPICAL DELIVERY INHALED/NASAL/PULMONARY DELIVERY IMPLANTABLE DELIVERY NANOPARTICLE DRUG DELIVERY SYSTEM BY THERAPEUTICS THERAPY CANCER THERAPY VACCINES ANTIBODY DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. BASED THERAPY NANOPARTICLE DRUG DELIVERY SYSTEM BY TECHNOLOGY NANOPARTICULATE ENCAPSULATION THE DENDRIMER-BASED TARGETED THERAPEUTICS TECHNOLOGY LIPOSOMES NANOTECHNOLOGY NANOTUBE TECHNOLOGIES NANOSHELL TECHNOLOGY NANOPARTICLES COATING TECHNOLOGY SILICA-CHITOSAN NANOCOMPOSITE NANOCRYSTAL TECHNOLOGY NANOSOME TECHNOLOGY NANOSUSPENSION TECHNOLOGY POLYMER THERAPEUTICS APPENDIX 1: LIST OF NANOPARTICLE DRUG DELIVERY PLATFORMS/TECHNOLOGIES APPENDIX 2: NANOPARTICLES IN DRUG DELIVERY PRODUCTS ON THE MARKET OR IN CLINICAL PHASE 1/2/3 APPENDIX 3: OVERVIEW OF NANOPARTICLE APPLICATIONS IN DRUG DELIVERY APPENDIX 4: DRUG DELIVERY COMPANY - COMPANIES WHO PRODUING NANOPARTICLES/TECHNOLOGIES ENABLE BETTER DRUG DELIVERY COMPOUNDS APPENDIX 5: DRUG FORMULATION COMPANY - COMPANIES WHO USING NANOPARTICLE-ENABLED FORMULATIONS TO ENHANCE DRUG DELIVERY Table of Exhibits For more information visit http://www.researchandmarkets.com/reports/c68525 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion